EUVIMEDEUVIMED entdecken
Crossref

Design and synthesis of novel piperazine-based sulfamate derivatives as steroid sulfatase inhibitors

Anil Ravi, Paul A Foster, Seyed-Omar Zaraei, Bilal O Alkubaisi, Hanan S Anbar, Randa El-Gamal, Farah Alsaafin, Amjad Alhalaweh, Mohammed I El-Gamal

Bioorganic Chemistry · 2026-07 · 175 · 109766

DOI: 10.1016/j.bioorg.2026.109766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-07. Verfasst von Anil Ravi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates. Hauptthemen laut MEDLINE: Steryl-Sulfatase, Drug Design, Enzyme Inhibitors, Sulfonic Acids. Die Arbeit nennt 20 Literaturangaben. Gefördert von: University of Sharjah.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Steroid sulfatase (STS) is emerging as a promising target in the treatment of hormone receptor-positive (HR+)/HER2-negative breast cancer. In this study, a series of new sulfamate-based arylamido-adamantane derivatives (1a-p) with a piperazine linker were designed and synthesized to enhance their potential as STS inhibitors by improving their physicochemical and pharmacokinetic properties. The biological screening and solubility measurement were performed to assess the compounds properties. Among the 16 synthesized compounds, 11 compounds with ortho-halo-substitution exhibited 90% STS inhibitory activity due to enhanced hydrogen bonding and enzyme-inhibitor complex stabilization. Cell-free (JEG-3 placental cell lysate) and whole-cell assays (using intact monolayers of JEG-3 cells) revealed that 4-carboxamido phenyl sulfamate derivatives, particularly compounds 1f (IC50 = 21.44 nM), 1b (IC50 = 38.58 nM) and 1c (IC50 = 44.08 nM) in cell free assay and 1b (IC₅₀ = 6.49 nM), 1c (IC₅₀ = 10.04 nM) and 1f (IC₅₀ = 21.44 nM) in whole cell assay exhibited potent STS inhibition. Notably, compound 1l showed poor cell-free potency (IC₅₀ = 202 nM) but significant whole-cell activity (IC₅₀ = 37.79 nM), highlighting improved lipid bilayer penetration. These findings validate the potential of piperazine-linked sulfamate derivatives as potent STS inhibitors that can offer new paths for hormone-dependent breast cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Steryl-SulfataseDrug DesignEnzyme InhibitorsSulfonic AcidsPiperazinesHumansStructure-Activity RelationshipMolecular StructureDose-Response Relationship, DrugPiperazineCell Line, Tumor

Stichwörter der Autor:innen

AdamantanePhysicochemical propertiesPiperazineSteroid sulfataseSulfamate

Substanzen

Steryl-SulfataseEnzyme Inhibitorssulfamic acidSulfonic AcidsPiperazinesPiperazine

Autor:innen und Institutionen

  • Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates.
  • Department of Metabolism and Systems Science, 2nd/3rd Floor IBR Tower, University of Birmingham, Birmingham B15 2TT, United Kingdom; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birming…
  • Department of Pharmaceutical Sciences, College of Pharmacy, Dubai Medical University, Dubai 19099, United Arab Emirates.
  • Department of Medical Biochemistry, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
  • Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates; Department of Pharmacy, Uppsala University, Uppsala Biomedical Centre, P.O. Box…
  • Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates; Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab E…

Förderung

  • University of Sharjah

Zitieren

APA

Ravi, A., Foster, P. A., Zaraei, S. O., Alkubaisi, B. O., Anbar, H. S., El-Gamal, R., Alsaafin, F., Alhalaweh, A., & El-Gamal, M. I. (2026). Design and synthesis of novel piperazine-based sulfamate derivatives as steroid sulfatase inhibitors. Bioorganic Chemistry, 175, 109766. https://doi.org/10.1016/j.bioorg.2026.109766

Vancouver

Ravi A, Foster PA, Zaraei SO, Alkubaisi BO, Anbar HS, El-Gamal R, et al. Design and synthesis of novel piperazine-based sulfamate derivatives as steroid sulfatase inhibitors. Bioorganic Chemistry. 2026;175:109766. doi:10.1016/j.bioorg.2026.109766

BibTeX
@article{Ravi2026,
  author = {Ravi, Anil and Foster, Paul A and Zaraei, Seyed-Omar and Alkubaisi, Bilal O and Anbar, Hanan S and El-Gamal, Randa and Alsaafin, Farah and Alhalaweh, Amjad and El-Gamal, Mohammed I},
  title = {Design and synthesis of novel piperazine-based sulfamate derivatives as steroid sulfatase inhibitors},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {175},
  pages = {109766},
  doi = {10.1016/j.bioorg.2026.109766}
}
Kostenlos starten →